Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02034123
Title Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

lung small cell carcinoma

Therapies

GSK2879552

Age Groups: adult
Covered Countries USA


No variant requirements are available.